ABEO
ABEONA THERAPEUTICS INC.
Company overview
- Market capitalization
- $302.50M
- Employees
- 226
- Latest publication
- 2026-09-29
About ABEONA THERAPEUTICS INC.
Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q1 20242024-03-31 · USD | Q4 20232023-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 11,380,000USD | 0USD | 400,000USD | 0USD | 4,782,000USD | 0USD | 0USD | 2,824,000USD |
| Cost Of Revenue | 4,177,000USD | 488,000USD | 100,000USD | 815,000USD | 776,000USD | 722,000USD | 724,000USD | 721,000USD |
| Gross Profit | 7,203,000USD | -488,000USD | 300,000USD | -815,000USD | -776,000USD | -722,000USD | -724,000USD | -721,000USD |
| Research Development | 5,021,000USD | 4,216,000USD | 5,943,000USD | 9,941,000USD | 8,994,000USD | 8,941,000USD | 7,207,000USD | 7,379,000USD |
| Selling General Administrative | 15,835,000USD | 19,314,000USD | 17,149,000USD | 9,786,000USD | 7,678,000USD | 6,404,000USD | 7,123,000USD | 5,830,000USD |
| Total Operating Expenses | 20,856,000USD | 23,530,000USD | 23,092,000USD | 19,727,000USD | 15,896,000USD | 15,345,000USD | 14,330,000USD | 12,488,000USD |
| Operating Income | -13,653,000USD | -24,018,000USD | -22,792,000USD | -19,727,000USD | -16,672,000USD | -15,345,000USD | -14,330,000USD | -13,209,000USD |
| Total Other Income Expense Net | -6,538,000USD | 3,660,000USD | 147,137,000USD | 7,698,000USD | 7,379,000USD | -14,924,000USD | -17,248,000USD | -3,382,000USD |
| Interest Income | 1,355,000USD | 1,672,000USD | 1,027,000USD | 1,310,000USD | 1,023,000USD | 1,189,000USD | 843,000USD | 743,000USD |
| Interest Expense | 696,000USD | 901,000USD | 957,000USD | 998,000USD | 1,082,000USD | 1,102,000USD | 952,000USD | 109,000USD |
| Income Before Tax | -20,191,000USD | -20,358,000USD | 124,345,000USD | -12,029,000USD | -9,293,000USD | -30,269,000USD | -31,578,000USD | -16,591,000USD |
| Income Tax Expense | 0USD | -15,197,000USD | 15,512,000USD | — | -680,724USD | — | 680,724USD | 677,188USD |
| Net Income | -20,191,000USD | -5,161,000USD | 108,833,000USD | -12,029,000USD | -9,293,000USD | -30,269,000USD | -31,578,000USD | -16,591,000USD |
| Net Income Applicable To Common Shares | -20,191,000USD | — | — | — | — | — | — | — |
| Net Interest Income | — | 771,000USD | 70,000USD | 312,000USD | -59,000USD | 87,000USD | -109,000USD | 634,000USD |
| Tax Provision | — | -15,197,000USD | 15,512,000USD | 0USD | — | 0USD | — | — |
| Net Income From Continuing Ops | — | -5,161,000USD | 108,833,000USD | -12,029,000USD | -9,293,000USD | -30,269,000USD | -31,578,000USD | -16,591,000USD |
| Ebit | — | -19,457,000USD | 125,302,000USD | -11,031,000USD | -8,213,000USD | -29,167,000USD | -30,626,000USD | -16,482,000USD |
| Ebitda | — | -18,569,000USD | 126,070,000USD | -10,216,000USD | -7,437,000USD | -28,445,000USD | -29,902,000USD | -15,761,000USD |
| Depreciation And Amortization | — | 888,000USD | 768,000USD | 815,000USD | 776,000USD | 722,000USD | 724,000USD | 721,000USD |
| Reconciled Depreciation | — | 888,000USD | 768,000USD | 815,000USD | 776,000USD | 722,000USD | 724,000USD | 721,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | 724,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20242024-12-31 · USD | FY 20192019-12-31 · USD | FY 20172017-12-31 · USD | FY 20142014-12-31 · USD | FY 20132013-12-31 · USD | FY 20122012-12-31 · USD | FY 20102010-12-31 · USD | FY 20072007-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 837,000USD | 925,000USD | 2,042,000USD | 4,404,000USD | 481,000USD | 57,000USD |
| Cost Of Revenue | 2,907,000USD | 48,566,000USD | 16,989,000USD | 11,000USD | 125,000USD | 267,000USD | 140,000USD | 6,678,000USD |
| Gross Profit | -2,907,000USD | -48,566,000USD | -16,152,000USD | 925,000USD | 1,917,000USD | 4,137,000USD | 341,000USD | 57,000USD |
| Research Development | 34,360,000USD | 53,766,000USD | 16,989,000USD | 333,000USD | 884,000USD | 2,010,000USD | 3,349,000USD | 2,602,000USD |
| Selling General Administrative | 29,851,000USD | 20,705,000USD | 10,943,000USD | 3,712,000USD | 4,834,000USD | 6,024,000USD | 4,511,000USD | 957,000USD |
| Unclassified Operating Expenses | -2,907,000USD | -45,947,000USD | — | — | — | — | — | — |
| Total Operating Expenses | 61,304,000USD | 28,524,000USD | 28,673,000USD | 4,056,000USD | 5,721,000USD | 8,453,000USD | 7,860,000USD | 6,957,000USD |
| Operating Income | -64,211,000USD | -77,090,000USD | -27,836,000USD | -3,131,000USD | -3,804,000USD | -4,316,000USD | -7,757,000USD | -6,900,000USD |
| Interest Income | 4,246,000USD | 1,208,000USD | 525,000USD | — | — | — | — | — |
| Interest Expense | 4,208,000USD | 400,000USD | 8,000USD | 582,000USD | 279,000USD | 608,000USD | 607,000USD | 3,514,000USD |
| Net Interest Income | 38,000USD | 808,000USD | 517,000USD | — | — | — | — | — |
| Income Before Tax | -63,734,000USD | -76,282,000USD | -27,319,000USD | -26,778,000USD | 4,449,000USD | -10,532,000USD | -7,537,000USD | -21,917,000USD |
| Tax Provision | 0USD | — | — | — | — | — | — | — |
| Net Income | -63,734,000USD | -76,282,000USD | -27,319,000USD | -26,778,000USD | 4,449,000USD | -10,532,000USD | -7,537,000USD | -21,744,000USD |
| Net Income From Continuing Ops | -63,734,000USD | -77,490,000USD | -27,319,000USD | -26,778,000USD | 4,449,000USD | — | — | — |
| Ebit | -59,526,000USD | -77,090,000USD | -27,319,000USD | -26,196,000USD | 4,728,000USD | -9,924,000USD | -6,930,000USD | -18,403,000USD |
| Ebitda | -56,619,000USD | -69,271,000USD | -26,578,000USD | -26,185,000USD | 4,731,000USD | -9,505,000USD | -6,692,000USD | -18,124,000USD |
| Depreciation And Amortization | 2,907,000USD | 7,819,000USD | 741,000USD | 11,000USD | 3,000USD | 419,000USD | 238,000USD | 279,000USD |
| Reconciled Depreciation | 2,907,000USD | 7,819,000USD | 741,000USD | — | — | — | — | — |
| Total Other Income Expense Net | 477,000USD | 808,000USD | 517,000USD | -23,647,000USD | 8,253,000USD | -6,216,000USD | 220,000USD | -15,017,000USD |
| Income Tax Expense | — | 400,000USD | 525,000USD | 582,000USD | 279,000USD | 608,000USD | -220,000USD | -61,000USD |
| Net Income Applicable To Common Shares | — | -76,282,000USD | -27,319,000USD | -29,653,000USD | 1,551,000USD | — | — | — |
| Non Operating Income Net Other | — | — | 525,000USD | -23,065,000USD | 8,532,000USD | — | — | — |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 3,119,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 179,507,000USD | 198,494,000USD | 219,570,000USD | 231,095,000USD | 246,233,000USD | 99,364,000USD | 108,931,000USD | 120,592,000USD |
| Cash And Equivalents | 56,229,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 146,826,000USD | 168,271,000USD | 191,404,000USD | 207,455,000USD | 225,518,000USD | 84,155,000USD | 97,720,000USD | 109,701,000USD |
| Short Term Investments | 90,597,000USD | 106,897,000USD | 112,967,000USD | 124,233,000USD | 61,983,000USD | 68,219,000USD | 74,363,000USD | 93,975,000USD |
| Total Current Assets | 164,578,000USD | 182,985,000USD | 204,906,000USD | 216,130,000USD | 232,262,000USD | 88,121,000USD | 100,853,000USD | 112,657,000USD |
| Other Current Assets | 1,942,000USD | 1,951,000USD | 1,294,000USD | 2,209,000USD | 2,428,000USD | 2,349,000USD | 1,481,000USD | 1,343,000USD |
| Other Non Current Assets | 827,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 51,449,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 24,806,000USD | 31,046,000USD | 29,570,000USD | 22,180,000USD | 34,517,000USD | 17,983,000USD | 16,587,000USD | 18,422,000USD |
| Other Current Liabilities | 7,197,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 128,058,000USD | 144,939,000USD | 159,216,000USD | 171,233,000USD | 163,576,000USD | 41,396,000USD | 44,031,000USD | 45,773,000USD |
| Total Equity Including Noncontrolling Interest | 128,058,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 13,333,000USD | 13,333,000USD | 12,222,000USD | 8,889,000USD | 5,556,000USD | 8,148,000USD | 5,926,000USD | 4,444,000USD |
| Long Term Debt | 1,655,000USD | 4,754,000USD | 7,813,000USD | 10,862,000USD | 14,005,000USD | 11,138,000USD | 13,037,000USD | 14,206,000USD |
| Deferred Revenue Non Current | 677,000USD | — | — | — | — | — | — | — |
| Net Receivables | 9,394,000USD | 6,709,000USD | 6,715,000USD | 1,616,000USD | 1,630,000USD | 1,617,000USD | 1,652,000USD | 1,613,000USD |
| Inventory | 5,921,000USD | 6,054,000USD | 5,493,000USD | 4,850,000USD | 2,686,000USD | — | 0USD | — |
| Property Plant Equipment Net | 14,102,000USD | 14,682,000USD | 13,883,000USD | 14,424,000USD | 13,633,000USD | 11,186,000USD | 7,982,000USD | 7,847,000USD |
| Accounts Payable | 2,994,000USD | 4,071,000USD | 7,889,000USD | 5,927,000USD | 7,337,000USD | 5,018,000USD | 3,441,000USD | 2,789,000USD |
| Short Term Debt | 1,280,000USD | 14,605,000USD | 13,086,000USD | 8,991,000USD | 6,093,000USD | 8,761,000USD | 6,749,000USD | 5,501,000USD |
| Common Stock | 572,000USD | 568,000USD | 550,000USD | 524,000USD | 512,000USD | 490,000USD | 457,000USD | 434,000USD |
| Retained Earnings | -779,341,000USD | -759,150,000USD | -742,075,000USD | -721,615,000USD | -716,454,000USD | -825,287,000USD | -813,258,000USD | -803,965,000USD |
| Accumulated Other Comprehensive Income | -79,000USD | -21,000USD | 138,000USD | 10,000USD | -45,000USD | -67,000USD | 8,000USD | -84,000USD |
| Total Liab | — | 53,555,000USD | 60,354,000USD | 59,862,000USD | 82,657,000USD | 57,968,000USD | 64,900,000USD | 74,819,000USD |
| Other Current Liab | — | 12,370,000USD | 8,595,000USD | 7,262,000USD | 5,575,000USD | 4,204,000USD | 6,397,000USD | 10,132,000USD |
| Capital Stock | — | 568,000USD | 550,000USD | 524,000USD | 512,000USD | 490,000USD | 457,000USD | 434,000USD |
| Cash | — | 61,374,000USD | 78,437,000USD | 83,222,000USD | 163,535,000USD | 15,936,000USD | 23,357,000USD | 15,726,000USD |
| Current Deferred Revenue | — | 425,000USD | — | — | — | — | — | — |
| Net Debt | — | -38,201,000USD | -53,469,000USD | -59,115,000USD | -139,459,000USD | 8,041,000USD | -309,000USD | 7,383,000USD |
| Short Long Term Debt Total | — | 23,173,000USD | 24,968,000USD | 24,107,000USD | 24,076,000USD | 23,977,000USD | 23,048,000USD | 23,109,000USD |
| Property Plant Equipment Gross | — | 32,590,000USD | 31,101,000USD | 30,780,000USD | 29,691,000USD | 26,699,000USD | 22,962,000USD | 22,288,000USD |
| Common Stock Shares Outstanding | — | 56,620,920shares | 66,135,821shares | 54,242,507shares | 66,640,620shares | 49,779,000shares | 41,048,000shares | 48,082,000shares |
| Non Current Assets Total | — | 15,509,000USD | 14,664,000USD | 14,965,000USD | 13,971,000USD | 11,243,000USD | 8,078,000USD | 7,935,000USD |
| Non Current Liabilities Total | — | 22,509,000USD | 30,784,000USD | 37,682,000USD | 48,140,000USD | 39,985,000USD | 48,313,000USD | 56,397,000USD |
| Non Currrent Assets Other | — | 827,000USD | 781,000USD | 541,000USD | 338,000USD | 57,000USD | 96,000USD | 88,000USD |
| Net Working Capital | — | 151,939,000USD | 175,336,000USD | 193,950,000USD | 197,745,000USD | 70,138,000USD | 84,266,000USD | 94,235,000USD |
| Unclassified Current Liabilities | — | -13,758,000USD | -12,222,000USD | -8,889,000USD | 9,956,000USD | -8,148,000USD | -5,926,000USD | -4,444,000USD |
| Unclassified Non Current Liabilities | — | 17,755,000USD | 22,971,000USD | 26,820,000USD | 34,135,000USD | 28,847,000USD | 35,276,000USD | 42,191,000USD |
| Unclassified Equity | — | 902,974,000USD | 900,053,000USD | 891,790,000USD | 879,051,000USD | 865,770,000USD | 856,367,000USD | 848,954,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 219,570,000USD | 108,931,000USD | 64,002,000USD | 64,214,000USD | 79,586,000USD | 151,198,000USD | 223,382,000USD | 174,399,000USD |
| Other Current Assets | 1,294,000USD | 1,481,000USD | 1,067,000USD | 762,000USD | 8,268,000USD | 2,708,000USD | 3,132,000USD | 3,802,000USD |
| Total Liab | 60,354,000USD | 64,900,000USD | 49,176,000USD | 37,453,000USD | 37,218,000USD | 48,647,000USD | 44,952,000USD | 40,354,000USD |
| Total Stockholder Equity | 159,216,000USD | 44,031,000USD | 14,826,000USD | 26,761,000USD | 42,368,000USD | 102,551,000USD | 178,430,000USD | 134,045,000USD |
| Other Current Liab | 8,595,000USD | 6,397,000USD | 10,566,000USD | 4,195,000USD | 10,184,000USD | 34,925,000USD | 32,943,000USD | 3,936,000USD |
| Common Stock | 550,000USD | 457,000USD | 265,000USD | 177,000USD | 1,472,000USD | 961,000USD | 836,000USD | 479,000USD |
| Capital Stock | 550,000USD | 457,000USD | 265,000USD | 177,000USD | 1,472,000USD | 961,000USD | 836,000USD | 479,000USD |
| Retained Earnings | -742,075,000USD | -813,258,000USD | -749,524,000USD | -695,336,000USD | -655,640,000USD | -570,704,000USD | -486,470,000USD | -410,188,000USD |
| Cash | 78,437,000USD | 23,357,000USD | 14,473,000USD | 14,217,000USD | 32,938,000USD | 12,596,000USD | 129,258,000USD | 18,750,000USD |
| Cash And Short Term Investments | 191,404,000USD | 97,720,000USD | 52,226,000USD | 52,149,000USD | 45,024,000USD | 95,034,000USD | 129,258,000USD | 84,968,000USD |
| Total Current Assets | 204,906,000USD | 100,853,000USD | 55,737,000USD | 53,099,000USD | 56,292,000USD | 97,742,000USD | 132,390,000USD | 88,851,000USD |
| Total Current Liabilities | 29,570,000USD | 16,587,000USD | 13,422,000USD | 7,779,000USD | 16,623,000USD | 41,959,000USD | 38,701,000USD | 20,354,000USD |
| Net Debt | -53,469,000USD | -309,000USD | -9,073,000USD | -6,590,000USD | -23,560,000USD | -3,865,000USD | -121,308,000USD | 11,250,000USD |
| Short Term Debt | 13,086,000USD | 6,749,000USD | 998,000USD | 1,773,000USD | 1,818,000USD | 2,043,000USD | 1,699,000USD | 10,000,000USD |
| Short Long Term Debt | 12,222,000USD | 5,926,000USD | — | — | — | 330,000USD | — | 10,000,000USD |
| Short Long Term Debt Total | 24,968,000USD | 23,048,000USD | 5,400,000USD | 7,627,000USD | 9,378,000USD | 8,731,000USD | 7,950,000USD | 30,000,000USD |
| Long Term Debt | 7,813,000USD | 13,037,000USD | — | — | — | 1,428,000USD | — | 20,000,000USD |
| Short Term Investments | 112,967,000USD | 74,363,000USD | 37,753,000USD | 37,932,000USD | 12,086,000USD | 82,438,000USD | 0USD | 66,218,000USD |
| Net Receivables | 6,715,000USD | 1,652,000USD | 2,444,000USD | 188,000USD | 3,000,000USD | 0USD | 0USD | 81,000USD |
| Inventory | 5,493,000USD | 0USD | — | 338,000USD | 1USD | — | — | 1USD |
| Accounts Payable | 7,889,000USD | 3,441,000USD | 1,858,000USD | 1,811,000USD | 4,325,000USD | 4,695,000USD | 3,763,000USD | 6,122,000USD |
| Property Plant Equipment Net | 13,883,000USD | 7,982,000USD | 7,988,000USD | 11,072,000USD | 21,742,000USD | 18,354,000USD | 21,204,000USD | 9,443,000USD |
| Property Plant Equipment Gross | 31,101,000USD | 22,962,000USD | 20,979,000USD | 11,072,000USD | 21,742,000USD | 18,354,000USD | 21,204,000USD | 9,443,000USD |
| Accumulated Other Comprehensive Income | 138,000USD | 8,000USD | -66,000USD | -129,000USD | -27,000USD | -10,000USD | 0USD | -1,560,000USD |
| Common Stock Shares Outstanding | 66,135,821shares | 41,048,000shares | 21,380,000shares | 7,862,000shares | 3,938,000shares | 3,707,000shares | 2,014,000shares | 1,901,000shares |
| Non Current Assets Total | 14,664,000USD | 8,078,000USD | 8,265,000USD | 11,115,000USD | 23,294,000USD | 53,456,000USD | 90,992,000USD | 85,548,000USD |
| Non Current Liabilities Total | 30,784,000USD | 48,313,000USD | 35,754,000USD | 29,674,000USD | 20,595,000USD | 6,688,000USD | 6,251,000USD | 20,000,000USD |
| Non Currrent Assets Other | 781,000USD | 96,000USD | 277,000USD | 43,000USD | 168,000USD | 1,136,000USD | 1,144,000USD | 597,000USD |
| Net Working Capital | 175,336,000USD | 84,266,000USD | 42,315,000USD | 45,320,000USD | 38,778,000USD | 55,783,000USD | 93,689,000USD | 68,497,000USD |
| Unclassified Current Liabilities | -12,222,000USD | -5,926,000USD | — | — | — | — | — | -10,000,000USD |
| Unclassified Non Current Liabilities | 22,971,000USD | 35,276,000USD | 35,754,000USD | 5,854,000USD | 16,367,000USD | — | — | -20,000,000USD |
| Unclassified Equity | 900,053,000USD | 856,367,000USD | 763,886,000USD | 721,872,000USD | 695,091,000USD | 671,343,000USD | 663,228,000USD | 544,835,000USD |
| Other Liab | — | — | — | 23,820,000USD | 4,028,000USD | — | — | 20,000,000USD |
| Other Assets | — | — | — | 43,000USD | 1,059,000USD | 1,136,000USD | 1,144,000USD | 597,000USD |
| Net Tangible Assets | — | — | — | 26,761,000USD | 49,991,000USD | 68,585,000USD | 178,430,000USD | 58,537,000USD |
| Intangible Assets | — | — | — | — | 1,384,000USD | 1,500,000USD | 36,178,000USD | 43,042,000USD |
| Good Will | — | — | — | — | 0USD | 32,466,000USD | 32,466,000USD | 32,466,000USD |
| Current Deferred Revenue | — | — | — | — | 296,000USD | 296,000USD | 296,000USD | 296,000USD |
| Non Current Liabilities Other | — | — | — | — | 200,000USD | 5,260,000USD | 6,251,000USD | — |
| Unclassified Non Current Assets | — | — | — | — | -1,059,000USD | -1,136,000USD | -1,144,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 1,355,000USD |
| Stock Based Compensation | 6,326,000USD |
| Change To Account Receivables | -3,247,000USD |
| Change To Inventory | -428,000USD |
| Change To Liabilities | -6,337,000USD |
| Change In Working Capital | -10,029,000USD |
| Operating Cash Flow | -37,300,000USD |
| Capital Expenditures | -1,414,000USD |
| Unclassified Investing Cash Flow | 22,063,000USD |
| Investing Cash Flow | 20,649,000USD |
| Net Debt Issuance | -5,556,000USD |
| Unclassified Financing Cash Flow | -1,000USD |
| Financing Cash Flow | -5,557,000USD |
| Change In Cash | -22,208,000USD |
| End Cash Flow | 56,229,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -17,075,000USD | -20,460,000USD | -5,161,000USD | 108,833,000USD | -12,029,000USD | -9,293,000USD | -30,269,000USD | 7,406,000USD |
| Depreciation | 869,000USD | 1,092,000USD | 888,000USD | 768,000USD | 815,000USD | 776,000USD | 722,000USD | 685,000USD |
| Stock Based Compensation | 2,957,000USD | -142,000USD | 2,689,000USD | 2,830,000USD | 2,701,000USD | 1,955,000USD | 1,804,000USD | 1,323,000USD |
| Other Non Cash Items | -5,099,000USD | 2,150,000USD | -2,578,000USD | -146,868,000USD | -6,467,000USD | -6,161,000USD | 15,687,000USD | -24,546,000USD |
| Change To Account Receivables | 6,000USD | -5,099,000USD | 14,000USD | -13,000USD | 35,000USD | -39,000USD | 27,000USD | 552,000USD |
| Change To Inventory | -561,000USD | -643,000USD | -2,164,000USD | -2,686,000USD | 0USD | — | 0USD | — |
| Change In Working Capital | -1,456,000USD | -593,000USD | -17,025,000USD | 15,653,000USD | -3,422,000USD | -3,836,000USD | -178,000USD | 2,448,000USD |
| Total Cash From Operating Activities | -19,804,000USD | -17,953,000USD | -21,187,000USD | -18,784,000USD | -18,402,000USD | -16,559,000USD | -12,234,000USD | -12,684,000USD |
| Capital Expenditures | -935,000USD | -1,153,000USD | -2,520,000USD | -2,901,000USD | -1,401,000USD | -606,000USD | -404,000USD | -711,000USD |
| Free Cash Flow | -20,739,000USD | -19,106,000USD | -23,707,000USD | -21,685,000USD | -19,803,000USD | -17,165,000USD | -12,638,000USD | -13,395,000USD |
| Investments | 5,898,000USD | 10,707,000USD | -64,627,000USD | 155,888,000USD | 4,213,000USD | 18,876,000USD | -6,167,000USD | -44,132,000USD |
| Total Cashflows From Investing Activities | 4,963,000USD | 9,554,000USD | -64,627,000USD | 155,888,000USD | 4,213,000USD | 18,876,000USD | -6,167,000USD | -44,132,000USD |
| Net Borrowings | -2,222,000USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | — |
| Total Cash From Financing Activities | -2,222,000USD | 3,614,000USD | 5,163,000USD | 10,495,000USD | 6,768,000USD | 5,314,000USD | -299,000USD | 73,684,000USD |
| Issuance Of Capital Stock | 0USD | 0USD | 0USD | 10,501,000USD | 6,799,000USD | 5,513,000USD | 0USD | 73,698,000USD |
| Change In Cash | -17,063,000USD | -4,785,000USD | -80,651,000USD | 147,599,000USD | -7,421,000USD | 7,631,000USD | -18,700,000USD | 16,868,000USD |
| Begin Period Cash Flow | 78,437,000USD | 83,222,000USD | 163,873,000USD | 16,274,000USD | 23,695,000USD | 16,064,000USD | 34,764,000USD | 17,896,000USD |
| End Period Cash Flow | 61,374,000USD | 78,437,000USD | 83,222,000USD | 163,873,000USD | 16,274,000USD | 23,695,000USD | 16,064,000USD | 34,764,000USD |
| Other Cashflows From Financing Activities | -2,222,000USD | — | 5,163,000USD | -6,000USD | -31,000USD | -199,000USD | -299,000USD | -14,000USD |
| Unclassified Financing Cash Flow | 2,222,000USD | 3,614,000USD | — | — | — | — | — | — |
| Unclassified Investing Cash Flow | — | — | 2,520,000USD | -149,465,000USD | 1,401,000USD | — | — | — |
| Other Cashflows From Investing Activities | — | — | — | 152,366,000USD | — | — | — | 18,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 71,183,000USD | -63,734,000USD | -54,188,000USD | -39,696,000USD | -84,936,000USD | -84,234,000USD | -76,282,000USD | -56,671,000USD |
| Depreciation | 3,563,000USD | 2,907,000USD | 3,198,000USD | 4,577,000USD | 4,464,000USD | 5,601,000USD | 8,677,000USD | 2,360,000USD |
| Stock Based Compensation | 10,779,000USD | 6,628,000USD | 4,768,000USD | 3,051,000USD | 8,916,000USD | 8,187,000USD | 8,237,000USD | 8,866,000USD |
| Other Non Cash Items | -156,464,000USD | 2,567,000USD | 11,001,000USD | -5,523,000USD | 24,154,000USD | 877,000USD | 101,000USD | 688,000USD |
| Change To Account Receivables | -5,063,000USD | 792,000USD | -2,041,000USD | 2,812,000USD | -3,000,000USD | -3,000,000USD | 81,000USD | 26,000USD |
| Change To Inventory | -5,493,000USD | 0USD | — | — | -16,081,000USD | — | -81,000USD | -1,027,000USD |
| Change In Working Capital | -5,387,000USD | -4,383,000USD | -1,788,000USD | -5,892,000USD | -18,263,000USD | 1,634,000USD | -3,553,000USD | 6,960,000USD |
| Total Cash From Operating Activities | -76,326,000USD | -56,015,000USD | -37,009,000USD | -43,483,000USD | -65,665,000USD | -35,019,000USD | -62,820,000USD | -39,111,000USD |
| Capital Expenditures | -7,975,000USD | -2,446,000USD | -331,000USD | -130,000USD | -4,151,000USD | -1,336,000USD | -6,508,000USD | -19,494,000USD |
| Free Cash Flow | -84,301,000USD | -58,461,000USD | -37,340,000USD | -43,613,000USD | -69,816,000USD | -36,355,000USD | -69,328,000USD | -58,605,000USD |
| Investments | -39,363,000USD | -39,240,000USD | 208,000USD | -23,964,000USD | 66,062,000USD | -83,714,000USD | 66,484,000USD | -65,592,000USD |
| Total Cashflows From Investing Activities | 105,028,000USD | -39,240,000USD | 208,000USD | -23,964,000USD | 66,062,000USD | -83,714,000USD | 59,976,000USD | -85,086,000USD |
| Net Borrowings | 0USD | 20,000,000USD | 0USD | — | 0USD | 1,758,000USD | 1,758,000USD | 1,758,000USD |
| Total Cash From Financing Activities | 26,040,000USD | 104,139,000USD | 37,057,000USD | 43,173,000USD | 24,861,000USD | 1,936,000USD | 113,902,000USD | 5,477,000USD |
| Issuance Of Capital Stock | 17,300,000USD | 85,628,000USD | 37,389,000USD | 69,428,000USD | 25,484,000USD | 1,000USD | 112,933,000USD | 0USD |
| Change In Cash | 54,742,000USD | 8,884,000USD | 256,000USD | -24,274,000USD | 25,258,000USD | -116,797,000USD | 111,058,000USD | -118,720,000USD |
| Begin Period Cash Flow | 23,695,000USD | 14,811,000USD | 14,555,000USD | 38,829,000USD | 13,571,000USD | 130,368,000USD | 19,310,000USD | 138,030,000USD |
| End Period Cash Flow | 78,437,000USD | 23,695,000USD | 14,811,000USD | 14,555,000USD | 38,829,000USD | 13,571,000USD | 130,368,000USD | 19,310,000USD |
| Other Cashflows From Investing Activities | 152,366,000USD | 18,000USD | 204,000USD | 1,734,000USD | -4,151,000USD | -1,336,000USD | 66,285,000USD | -19,494,000USD |
| Other Cashflows From Financing Activities | -37,000USD | -1,489,000USD | -332,000USD | -3,787,000USD | 831,000USD | 177,000USD | 969,000USD | 5,477,000USD |
| Unclassified Financing Cash Flow | 8,777,000USD | — | 37,571,000USD | 73,210,000USD | 24,030,000USD | — | 93,245,000USD | -7,235,000USD |
| Unclassified Investing Cash Flow | — | 2,428,000USD | — | -1,604,000USD | 8,302,000USD | 2,672,000USD | -66,285,000USD | 19,494,000USD |
| Sale Purchase Of Stock | — | — | -182,000USD | -26,250,000USD | 0USD | 177,000USD | 17,930,000USD | 5,477,000USD |
| Change To Liabilities | — | — | — | -5,490,000USD | 825,000USD | -2,178,000USD | -1,707,000USD | 7,961,000USD |
| Cash And Cash Equivalents Changes | — | — | — | — | — | -116,797,000USD | 111,058,000USD | -118,720,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | — | 32,916,000USD | — | -1,314,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| FY 2025Yearly · 2025-12-31 | Product | License | 3,400,000 | USD | 0001493152-26-010413 |
| FY 2025Yearly · 2025-12-31 | Product | Product | 2,420,000 | USD | 0001493152-26-010413 |
| FY 2018Yearly · 2018-12-31 | Product | Foundation Revenues | 2,796,000 | USD | 0001493152-20-004015 |
| FY 2018Yearly · 2018-12-31 | Product | License Revenues | 0 | USD | 0001493152-20-004015 |
| FY 2018Yearly · 2018-12-31 | Product | Royalty | 202,000 | USD | 0001493152-20-004015 |
| FY 2017Yearly · 2017-12-31 | Product | Grant | 0 | USD | 0001144204-19-014623 |
| FY 2017Yearly · 2017-12-31 | Product | License | 602,000 | USD | 0001144204-19-014623 |
| FY 2017Yearly · 2017-12-31 | Product | Royalty | 235,000 | USD | 0001144204-19-014623 |
| FY 2016Yearly · 2016-12-31 | Product | Grant | 0 | USD | 0001144204-19-014623 |
| FY 2016Yearly · 2016-12-31 | Product | License | 602,000 | USD | 0001144204-19-014623 |
| FY 2016Yearly · 2016-12-31 | Product | Royalty | 287,000 | USD | 0001144204-19-014623 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.